WO2017134685A3 - Nouveaux composés hydrazino utilisés comme inhibiteurs de btk - Google Patents
Nouveaux composés hydrazino utilisés comme inhibiteurs de btk Download PDFInfo
- Publication number
- WO2017134685A3 WO2017134685A3 PCT/IN2017/050048 IN2017050048W WO2017134685A3 WO 2017134685 A3 WO2017134685 A3 WO 2017134685A3 IN 2017050048 W IN2017050048 W IN 2017050048W WO 2017134685 A3 WO2017134685 A3 WO 2017134685A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel
- btk inhibitors
- compounds
- hydrazino compounds
- hydrazino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne de nouveaux composés hydrazino de Formule (I) utilisés comme inhibiteurs de tyrosine kinase de Bruton, leur procédé de préparation, et l'utilisation des composés dans la préparation de compositions pharmaceutiques pour le traitement thérapeutique de troubles impliquant une médiation de la tyrosine kinase de Bruton chez l'homme.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201621003737 | 2016-02-02 | ||
IN201621003737 | 2016-02-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2017134685A2 WO2017134685A2 (fr) | 2017-08-10 |
WO2017134685A3 true WO2017134685A3 (fr) | 2018-06-28 |
Family
ID=59500779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2017/050048 WO2017134685A2 (fr) | 2016-02-02 | 2017-02-02 | Nouveaux composés hydrazino utilisés comme inhibiteurs de btk |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017134685A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109111446B (zh) * | 2017-06-22 | 2021-11-30 | 上海度德医药科技有限公司 | 一种具有药物活性的杂芳基化合物 |
CA3224945A1 (fr) | 2018-07-31 | 2020-02-06 | Loxo Oncology, Inc. | Dispersions sechees par pulverisation, formulations et polymorphies de (s)-5-amino-3-(4-((5 fluoro-2-methoxybenzamido)methyl)phenyl)(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide |
CN113544130B (zh) * | 2019-05-31 | 2024-01-09 | 西藏海思科制药有限公司 | 一种btk抑制剂环衍生物及其制备方法和药学上的应用 |
CN111018865B (zh) * | 2019-10-17 | 2021-01-15 | 山东大学 | 1-取代苄基吡唑并嘧啶衍生物及其制备方法与应用 |
CN116323594A (zh) * | 2020-11-25 | 2023-06-23 | 四川海思科制药有限公司 | 一种btk降解剂的制备方法 |
TW202221002A (zh) * | 2020-11-25 | 2022-06-01 | 大陸商四川海思科製藥有限公司 | 一種btk降解劑的製備方法 |
WO2023023537A1 (fr) * | 2021-08-17 | 2023-02-23 | Endotarget Inc. | Composés et méthodes pour la dégradation ciblée de la tyrosine kinase de bruton |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008039218A2 (fr) * | 2006-09-22 | 2008-04-03 | Pharmacyclics, Inc. | Inhibiteurs de la tyrosine kinase de bruton |
WO2013177668A1 (fr) * | 2012-05-31 | 2013-12-05 | Pharmascience, Inc. | Inhibiteurs de protéine kinases |
WO2014005217A1 (fr) * | 2012-07-06 | 2014-01-09 | Pharmascience Inc. | Inhibiteurs de protéines kinases |
-
2017
- 2017-02-02 WO PCT/IN2017/050048 patent/WO2017134685A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008039218A2 (fr) * | 2006-09-22 | 2008-04-03 | Pharmacyclics, Inc. | Inhibiteurs de la tyrosine kinase de bruton |
WO2013177668A1 (fr) * | 2012-05-31 | 2013-12-05 | Pharmascience, Inc. | Inhibiteurs de protéine kinases |
WO2014005217A1 (fr) * | 2012-07-06 | 2014-01-09 | Pharmascience Inc. | Inhibiteurs de protéines kinases |
Also Published As
Publication number | Publication date |
---|---|
WO2017134685A2 (fr) | 2017-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017134685A3 (fr) | Nouveaux composés hydrazino utilisés comme inhibiteurs de btk | |
PH12020500265A1 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
PH12017502203A1 (en) | Tyrosine kinase inhibitors | |
PH12016500531A1 (en) | Compound inhibiting activities of btk and/or jak3 kinases | |
MX2021007432A (es) | Compuestos y composiciones para inhibir la actividad de shp2. | |
GEP20217248B (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
WO2016172134A3 (fr) | Nouveaux composés | |
SA515360007B1 (ar) | مركبات عطرية غير متجانسة كمثبطات بروتونز تيروسين كيناز ( btk) | |
WO2017205536A3 (fr) | Composés thérapeutiques et leurs utilisations | |
MX2021004431A (es) | Procesos novedosos. | |
MD4800C1 (ro) | Compuşi de aminopirimidinil ca inhibitori de JAK | |
WO2016109217A3 (fr) | Inhibiteurs de la btk | |
NZ729603A (en) | Heteroaryl compounds as btk inhibitors and uses thereof | |
WO2015101958A3 (fr) | Nouveaux inhibiteurs de glutaminase | |
WO2015108490A3 (fr) | Dérivés hétéroarylalcyne et leurs utilisations | |
EP4356969A3 (fr) | Composés de pyridazinone tricycliques fusionnés utiles pour traiter des infections par orthomyxovirus | |
WO2017128917A8 (fr) | Dérivés de cycles condensés de parazole et procédé de préparation de ces derniers, et application de ces derniers dans le traitement de cancers, d'inflammation et de maladies immunitaires | |
SA519401322B1 (ar) | مركبات أريل كربوكساميد غير متجانسة كمثطبات لكيناز بروتين سيرين/ ثريونين متداخل مع المستقبل 2 | |
EA201692260A1 (ru) | Соединения 1,3,4-тиадиазола и их применение в лечении рака | |
WO2016102672A3 (fr) | Composés pharmaceutiquement actifs | |
NZ702253A (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
EP4272832A3 (fr) | Composés antimicrobiens, compositions et leurs utilisations | |
MX2017014752A (es) | Nuevos etinos de amidoheteroaril aroil hidrazida. | |
EA201990399A1 (ru) | Соединения, композиции и их применение | |
PH12017501668A1 (en) | Bace1 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17747131 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17747131 Country of ref document: EP Kind code of ref document: A2 |